{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:13:58Z","timestamp":1793164438079,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-CE16-0009"],"award-info":[{"award-number":["ANR-17-CE16-0009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CE17-0029"],"award-info":[{"award-number":["ANR-22-CE17-0029"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007379","name":"Fondation pour l'Aide \u00e0 la Recherche sur la Scl\u00e9rose en Plaques","doi-asserted-by":"publisher","award":["ARSEP-1284"],"award-info":[{"award-number":["ARSEP-1284"]}],"id":[{"id":"10.13039\/100007379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oligodendrocytes are critical for CNS myelin formation and are involved in preterm-birth brain injury (PBI) and multiple sclerosis (MS), both of which lack effective treatments. We present a pharmacogenomic approach that identifies compounds with potent pro-oligodendrogenic activity, selected through a scoring strategy (OligoScore) based on their modulation of oligodendrogenic and (re)myelination-related transcriptional programs. Through in vitro neural and oligodendrocyte progenitor cell (OPC) cultures, ex vivo cerebellar explants, and in vivo mouse models of PBI and MS, we identify FDA-approved leucovorin and dyclonine as promising candidates. In a neonatal chronic hypoxia mouse model mimicking PBI, both compounds promote neural progenitor cell proliferation and oligodendroglial fate acquisition, with leucovorin further enhancing differentiation. In an adult MS model of focal de\/remyelination, they improve lesion repair by promoting OPC differentiation while preserving the OPC pool. Additionally, they shift microglia from a pro-inflammatory to a pro-regenerative profile and enhance myelin debris clearance. These findings support the repurposing of leucovorin and dyclonine for clinical trials targeting myelin disorders, offering potential therapeutic avenues for PBI and MS.<\/jats:p>","DOI":"10.1038\/s41467-024-54003-9","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T18:21:18Z","timestamp":1731522078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair"],"prefix":"10.1038","volume":"15","author":[{"given":"Jean-Baptiste","family":"Hur\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Foucault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litsa Maria","family":"Ghayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentine","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5280-7126","authenticated-orcid":false,"given":"Nicolas","family":"Vachoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6772-8168","authenticated-orcid":false,"given":"Lucas","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihab","family":"Azmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalija","family":"Ivljanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0803-1177","authenticated-orcid":false,"given":"Alvaro","family":"Arevalo-Nuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Pigache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Bouslama-Oueghlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie-Anne","family":"Chemelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Aim\u00e9e","family":"Dronne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1243-7413","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Terreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9533-4908","authenticated-orcid":false,"given":"Bassem","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gueyffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Raineteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Parras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"54003_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.siny.2015.12.007","volume":"21","author":"MS Harrison","year":"2016","unstructured":"Harrison, M. S. & Goldenberg, R. L. Global burden of prematurity. Semin. Fetal Neonatal Med. 21, 74\u201379 (2016).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"54003_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.clp.2017.01.003","volume":"44","author":"TM Luu","year":"2017","unstructured":"Luu, T. M., Rehman Mian, M. O. & Nuyt, A. M. Long-term impact of preterm birth: Neurodevelopmental and physical health outcomes. Clin. Perinatol. 44, 305\u2013314 (2017).","journal-title":"Clin. Perinatol."},{"key":"54003_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ijgo.13195","volume":"150","author":"SR Walani","year":"2020","unstructured":"Walani, S. R. Global burden of preterm birth. Int. J. Gynecol. Obstet. 150, 31\u201333 (2020).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"54003_CR4","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1523\/JNEUROSCI.21-04-01302.2001","volume":"21","author":"SA Back","year":"2001","unstructured":"Back, S. A. et al. Late oligodendrocyte progenitors coincide with the developmental Window of vulnerability for human perinatal white matter injury. J. Neurosci. 21, 1302\u20131312 (2001).","journal-title":"J. Neurosci."},{"key":"54003_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","volume":"8","author":"JJ Volpe","year":"2009","unstructured":"Volpe, J. J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8, 110\u2013124 (2009).","journal-title":"Lancet Neurol."},{"key":"54003_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2021.03.017","volume":"118","author":"JL Fletcher","year":"2021","unstructured":"Fletcher, J. L., Makowiecki, K., Cullen, C. L. & Young, K. M. Oligodendrogenesis and myelination regulate cortical development, plasticity and circuit function. Semin. Cell Dev. Biol. 118, 14\u201323 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"54003_CR7","doi-asserted-by":"crossref","unstructured":"Lassmann, H. Multiple Sclerosis Pathology. (2018).","DOI":"10.1101\/cshperspect.a028936"},{"key":"54003_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. Multiple sclerosis. N. Engl. J. Med. 378, 169\u2013180 (2018).","journal-title":"N. Engl. J. Med."},{"key":"54003_CR9","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser, S. L. & Cree, B. A. C. Treatment of multiple sclerosis: A review. Am. J. Med. 133, 1380\u20131390.e1382 (2020).","journal-title":"Am. J. Med."},{"key":"54003_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/280395a0","volume":"280","author":"KJ Smith","year":"1979","unstructured":"Smith, K. J., Blakemore, W. F. & McDonald, W. I. Central remyelination restores secure conduction. Nature 280, 395\u2013396 (1979).","journal-title":"Nature"},{"key":"54003_CR11","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awn080","volume":"131","author":"KA Irvine","year":"2008","unstructured":"Irvine, K. A. & Blakemore, W. F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131, 1464\u20131477 (2008).","journal-title":"Brain"},{"key":"54003_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/120.1.27","volume":"120","author":"ND Jeffery","year":"1997","unstructured":"Jeffery, N. D. Blakemore WF. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120, 27\u201337 (1997).","journal-title":"Brain"},{"key":"54003_CR13","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1073\/pnas.0812500106","volume":"106","author":"ID Duncan","year":"2009","unstructured":"Duncan, I. D., Brower, A., Kondo, Y., Curlee, J. F. & Schultz, R. D. Extensive remyelination of the CNS leads to functional recovery. Proc. Natl. Acad. Sci. USA 106, 6832\u20136836 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54003_CR14","doi-asserted-by":"publisher","first-page":"14128","DOI":"10.1523\/JNEUROSCI.3491-13.2014","volume":"34","author":"YL Xing","year":"2014","unstructured":"Xing, Y. L. et al. Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination. J. Neurosci. 34, 14128\u201314146 (2014).","journal-title":"J. Neurosci."},{"key":"54003_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature14957","volume":"526","author":"J Samanta","year":"2015","unstructured":"Samanta, J. et al. Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination. Nature 526, 448\u2013452 (2015).","journal-title":"Nature"},{"key":"54003_CR16","doi-asserted-by":"publisher","first-page":"E11807","DOI":"10.1073\/pnas.1808064115","volume":"115","author":"ID Duncan","year":"2018","unstructured":"Duncan, I. D. et al. The adult oligodendrocyte can participate in remyelination. Proc. Natl. Acad. Sci. USA 115, E11807\u2013E11816 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54003_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","volume":"566","author":"MSY Yeung","year":"2019","unstructured":"Yeung, M. S. Y. et al. Dynamics of oligodendrocyte generation in multiple sclerosis. Nature 566, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"54003_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41593-020-0637-3","volume":"23","author":"CM Bacmeister","year":"2020","unstructured":"Bacmeister, C. M. et al. Motor learning promotes remyelination via new and surviving oligodendrocytes. Nat. Neurosci. 23, 819\u2013831 (2020).","journal-title":"Nat. Neurosci."},{"key":"54003_CR19","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.neuron.2023.03.031","volume":"111","author":"A Mezydlo","year":"2023","unstructured":"Mezydlo, A. et al. Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex. Neuron 111, 1748\u20131759 (2023).","journal-title":"Neuron"},{"key":"54003_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.24620","volume":"79","author":"B Bodini","year":"2016","unstructured":"Bodini, B. et al. Dynamic imaging of individual remyelination profiles in multiple sclerosis. Ann. Neurol. 79, 726\u2013738 (2016).","journal-title":"Ann. Neurol."},{"key":"54003_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/glia.23711","volume":"68","author":"DA Galloway","year":"2020","unstructured":"Galloway, D. A., Gowing, E., Setayeshgar, S. & Kothary, R. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination. Glia 68, 859\u2013877 (2020).","journal-title":"Glia"},{"key":"54003_CR22","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/brain\/awl217","volume":"129","author":"P Patrikios","year":"2006","unstructured":"Patrikios, P. et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165\u20133172 (2006).","journal-title":"Brain"},{"key":"54003_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nm.3618","volume":"20","author":"F Mei","year":"2014","unstructured":"Mei, F. et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat. Med. 20, 954\u2013960 (2014).","journal-title":"Nat. Med."},{"key":"54003_CR24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1523\/JNEUROSCI.3608-15.2016","volume":"36","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Clemastine enhances myelination in the prefrontal cortex and rescues behavioral changes in socially isolated mice. J. Neurosci. 36, 957\u2013962 (2016).","journal-title":"J. Neurosci."},{"key":"54003_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/(SICI)1097-4695(19990915)40:4<497::AID-NEU7>3.0.CO;2-#","volume":"40","author":"A Rodriguez-Pena","year":"1999","unstructured":"Rodriguez-Pena, A. Oligodendrocyte development and thyroid hormone. J. Neurobiol. 40, 497\u2013512 (1999).","journal-title":"J. Neurobiol."},{"key":"54003_CR26","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1210\/en.2004-0065","volume":"145","author":"CM Schoonover","year":"2004","unstructured":"Schoonover, C. M. et al. Thyroid hormone regulates oligodendrocyte accumulation in developing rat brain white matter tracts. Endocrinology 145, 5013\u20135020 (2004).","journal-title":"Endocrinology"},{"key":"54003_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc2044","volume":"7","author":"J Lamb","year":"2007","unstructured":"Lamb, J. The connectivity map: a new tool for biomedical research. Nat. Rev. Cancer 7, 54\u201360 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"54003_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/acel.12432","volume":"15","author":"S Calvert","year":"2016","unstructured":"Calvert, S. et al. A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans. Aging Cell 15, 256\u2013266 (2016).","journal-title":"Aging Cell"},{"key":"54003_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/acel.12163","volume":"13","author":"X Ye","year":"2014","unstructured":"Ye, X., Linton, J. M., Schork, N. J., Buck, L. B. & Petrascheck, M. A pharmacological network for lifespan extension in Caenorhabditis elegans. Aging Cell 13, 206\u2013215 (2014).","journal-title":"Aging Cell"},{"key":"54003_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/acel.12626","volume":"16","author":"M Ziehm","year":"2017","unstructured":"Ziehm, M. et al. Drug repurposing for aging research using model organisms. Aging Cell 16, 1006\u20131015 (2017).","journal-title":"Aging Cell"},{"key":"54003_CR31","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.aaf6463","volume":"352","author":"S Marques","year":"2016","unstructured":"Marques, S. et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352, 1326\u20131329 (2016).","journal-title":"Science"},{"key":"54003_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.devcel.2018.07.005","volume":"46","author":"S Marques","year":"2018","unstructured":"Marques, S. et al. Transcriptional convergence of oligodendrocyte lineage progenitors during development. Dev. Cell 46, 504\u2013517.e507 (2018).","journal-title":"Dev. Cell"},{"key":"54003_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","volume":"566","author":"S J\u00e4kel","year":"2019","unstructured":"J\u00e4kel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543\u2013547 (2019).","journal-title":"Nature"},{"key":"54003_CR34","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","volume":"24","author":"AM Falc\u00e3o","year":"2018","unstructured":"Falc\u00e3o, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837\u20131844 (2018).","journal-title":"Nat. Med."},{"key":"54003_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2018.07.028","volume":"174","author":"A Saunders","year":"2018","unstructured":"Saunders, A. et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell 174, 1015\u20131030 (2018).","journal-title":"Cell"},{"key":"54003_CR36","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"54003_CR37","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.23-10-04240.2003","volume":"23","author":"SO Suzuki","year":"2003","unstructured":"Suzuki, S. O. & Goldman, J. E. Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: a dynamic study of glial and neuronal progenitor migration. J. Neurosci. 23, 4240\u20134250 (2003).","journal-title":"J. Neurosci."},{"key":"54003_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nn1620","volume":"9","author":"N Kessaris","year":"2006","unstructured":"Kessaris, N. et al. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat. Neurosci. 9, 173\u2013179 (2006).","journal-title":"Nat. Neurosci."},{"key":"54003_CR39","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/stem.2017","volume":"33","author":"K Azim","year":"2015","unstructured":"Azim, K. et al. Transcriptional hallmarks of heterogeneous neural stem cell niches of the subventricular Zone. Stem Cells 33, 2232\u20132242 (2015).","journal-title":"Stem Cells"},{"key":"54003_CR40","doi-asserted-by":"publisher","first-page":"e2000698","DOI":"10.1371\/journal.pbio.2000698","volume":"15","author":"K Azim","year":"2017","unstructured":"Azim, K. et al. Pharmacogenomic identification of small molecules for lineage specific manipulation of subventricular zone germinal activity. PLOS Biol. 15, e2000698 (2017).","journal-title":"PLOS Biol."},{"key":"54003_CR41","unstructured":"Buchanan, J. et al. Oligodendrocyte precursor cells ingest axons in the mouse neocortex. Proc. Natl. Acad. Sci. USA 119, e2202580119 (2022)."},{"key":"54003_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41593-022-01023-7","volume":"25","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y., Petrucco, L., Hoodless, L. J., Portugues, R. & Czopka, T. Oligodendrocyte precursor cells sculpt the visual system by regulating axonal remodeling. Nat. Neurosci. 25, 280\u2013284 (2022).","journal-title":"Nat. Neurosci."},{"key":"54003_CR43","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.neuron.2021.02.003","volume":"109","author":"SE Pease-Raissi","year":"2021","unstructured":"Pease-Raissi, S. E. & Chan, J. R. Building a (w)rapport between neurons and oligodendroglia: Reciprocal interactions underlying adaptive myelination. Neuron 109, 1258\u20131273 (2021).","journal-title":"Neuron"},{"key":"54003_CR44","doi-asserted-by":"crossref","unstructured":"Foster, A. Y., Bujalka, H. & Emery, B. Axoglial interactions in myelin plasticity: Evaluating the relationship between neuronal activity and oligodendrocyte dynamics. Glia 11, 2038\u20132049 (2019).","DOI":"10.1002\/glia.23629"},{"key":"54003_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-765","volume":"14","author":"G Williams","year":"2013","unstructured":"Williams, G. SPIEDw: a searchable platform-independent expression database web tool. BMC Genomics 14, 765 (2013).","journal-title":"BMC Genomics"},{"key":"54003_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0092-8674(02)00678-5","volume":"109","author":"QR Lu","year":"2002","unstructured":"Lu, Q. R. et al. Common developmental requirement for Olig function indicates a motor neuron\/oligodendrocyte connection. Cell 109, 75\u201386 (2002).","journal-title":"Cell"},{"key":"54003_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cell.2012.12.006","volume":"152","author":"Y Yu","year":"2013","unstructured":"Yu, Y. et al. Olig2 Targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 152, 248\u2013261 (2013).","journal-title":"Cell"},{"key":"54003_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1101\/gad.215802","volume":"16","author":"CC Stolt","year":"2002","unstructured":"Stolt, C. C. et al. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 16, 165\u2013170 (2002).","journal-title":"Genes Dev."},{"key":"54003_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.biocel.2009.07.014","volume":"42","author":"CC Stolt","year":"2010","unstructured":"Stolt, C. C. & Wegner, M. SoxE function in vertebrate nervous system development. Int. J. Biochem. Cell Biol. 42, 437\u2013440 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"54003_CR50","doi-asserted-by":"publisher","first-page":"12633","DOI":"10.1523\/JNEUROSCI.2801-06.2006","volume":"26","author":"T Nakazawa","year":"2006","unstructured":"Nakazawa, T. et al. Tumor necrosis factor-\u03b1 mediates oligodendrocyte death and delayed retinal Ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 26, 12633\u201312641 (2006).","journal-title":"J. Neurosci."},{"key":"54003_CR51","doi-asserted-by":"publisher","first-page":"47.24","DOI":"10.4049\/jimmunol.194.Supp.47.24","volume":"194","author":"S Minchenberg","year":"2015","unstructured":"Minchenberg, S., LaRocca, D. & Massa, P. Induction of arginase-1 by TNF-\u03b1 in oligodendrocytes is controlled by SHP-1 (BA3P.119). J. Immunol. 194, 47.24\u201347.24 (2015).","journal-title":"J. Immunol."},{"key":"54003_CR52","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1073\/pnas.1006496107","volume":"107","author":"JA Sloane","year":"2010","unstructured":"Sloane, J. A. et al. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc. Natl. Acad. Sci. USA 107, 11555\u201311560 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54003_CR53","doi-asserted-by":"publisher","first-page":"E8246","DOI":"10.1073\/pnas.1802620115","volume":"115","author":"C Marie","year":"2018","unstructured":"Marie, C. et al. Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8. Proc. Natl. Acad. Sci. USA 115, E8246\u2013E8255 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54003_CR54","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41419-022-05483-4","volume":"13","author":"A-L Schang","year":"2022","unstructured":"Schang, A.-L. et al. Epigenetic priming of immune\/inflammatory pathways activation and abnormal activity of cell cycle pathway in a perinatal model of white matter injury. Cell Death Dis. 13, 1038 (2022).","journal-title":"Cell Death Dis."},{"key":"54003_CR55","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green, A. J. et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 390, 2481\u20132489 (2017).","journal-title":"Lancet"},{"key":"54003_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02119-6","volume":"8","author":"S Faissner","year":"2017","unstructured":"Faissner, S. et al. Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic. Nat. Commun. 8, 1990 (2017).","journal-title":"Nat. Commun."},{"key":"54003_CR57","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1523\/JNEUROSCI.3510-14.2015","volume":"35","author":"K Abiraman","year":"2015","unstructured":"Abiraman, K. et al. Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair. J. Neurosci. 35, 3676\u20133688 (2015).","journal-title":"J. Neurosci."},{"key":"54003_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/srep16676","volume":"5","author":"M Barbierato","year":"2015","unstructured":"Barbierato, M. et al. Co-ultramicronized palmitoylethanolamide\/luteolin promotes the maturation of oligodendrocyte precursor cells. Sci. Rep. 5, 16676 (2015).","journal-title":"Sci. Rep."},{"key":"54003_CR59","doi-asserted-by":"crossref","unstructured":"Hubler, Z. et al. Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination. Nature 560, 372\u2013376 (2018).","DOI":"10.1038\/s41586-018-0360-3"},{"key":"54003_CR60","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature14335","volume":"522","author":"FJ Najm","year":"2015","unstructured":"Najm, F. J. et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature 522, 216\u2013220 (2015).","journal-title":"Nature"},{"key":"54003_CR61","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1126\/science.1553558","volume":"255","author":"BA Reynolds","year":"1992","unstructured":"Reynolds, B. A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707\u20131710 (1992).","journal-title":"Science"},{"key":"54003_CR62","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1038\/sj.emboj.7600447","volume":"23","author":"CM Parras","year":"2004","unstructured":"Parras, C. M. et al. Mash1 specifies neurons and oligodendrocytes in the postnatal brain. Embo J. 23, 4495\u20134505 (2004).","journal-title":"Embo J."},{"key":"54003_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep45780","volume":"7","author":"C Eleuteri","year":"2017","unstructured":"Eleuteri, C. et al. A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials. Sci. Rep. 7, 45780 (2017).","journal-title":"Sci. Rep."},{"key":"54003_CR64","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1242\/dev.120.5.1097","volume":"120","author":"BA Barres","year":"1994","unstructured":"Barres, B. A., Lazar, M. A. & Raff, M. C. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120, 1097\u20131108 (1994).","journal-title":"Development"},{"key":"54003_CR65","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/BF03344003","volume":"25","author":"J Bernal","year":"2002","unstructured":"Bernal, J. Action of thyroid hormone in brain. J. Endocrinol. Investig. 25, 268\u2013288 (2002).","journal-title":"J. Endocrinol. Investig."},{"key":"54003_CR66","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/glia.24001","volume":"69","author":"L Baudouin","year":"2021","unstructured":"Baudouin, L. et al. Co-culture of exogenous oligodendrocytes with unmyelinated cerebella: Revisiting ex vivo models and new tools to study myelination. Glia 69, 1916\u20131931 (2021).","journal-title":"Glia"},{"key":"54003_CR67","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41593-019-0418-z","volume":"22","author":"AF Lloyd","year":"2019","unstructured":"Lloyd, A. F. et al. Central nervous system regeneration is driven by microglia necroptosis and repopulation. Nat. Neurosci. 22, 1046\u20131052 (2019).","journal-title":"Nat. Neurosci."},{"key":"54003_CR68","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron, V. E. et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16, 1211\u20131218 (2013). advance online publication.","journal-title":"Nat. Neurosci."},{"key":"54003_CR69","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41593-020-0654-2","volume":"23","author":"AN Hughes","year":"2020","unstructured":"Hughes, A. N. & Appel, B. Microglia phagocytose myelin sheaths to modify developmental myelination. Nat. Neurosci. 23, 1055\u20131066 (2020).","journal-title":"Nat. Neurosci."},{"key":"54003_CR70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-017-1747-1","volume":"134","author":"N Hagemeyer","year":"2017","unstructured":"Hagemeyer, N. et al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 134, 441\u2013458 (2017).","journal-title":"Acta Neuropathol."},{"key":"54003_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby, L. et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat. Commun. 10, 3887 (2019).","journal-title":"Nat. Commun."},{"key":"54003_CR72","doi-asserted-by":"publisher","first-page":"108047","DOI":"10.1016\/j.celrep.2020.108047","volume":"32","author":"AD Nemes-Baran","year":"2020","unstructured":"Nemes-Baran, A. D., White, D. R. & DeSilva, T. M. Fractalkine-dependent microglial pruning of viable oligodendrocyte progenitor cells regulates myelination. Cell Rep. 32, 108047 (2020).","journal-title":"Cell Rep."},{"key":"54003_CR73","doi-asserted-by":"publisher","first-page":"108835","DOI":"10.1016\/j.celrep.2021.108835","volume":"34","author":"K Shen","year":"2021","unstructured":"Shen, K. et al. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination. Cell Rep. 34, 108835 (2021).","journal-title":"Cell Rep."},{"key":"54003_CR74","doi-asserted-by":"publisher","first-page":"14775","DOI":"10.1523\/JNEUROSCI.2060-12.2012","volume":"32","author":"B Jablonska","year":"2012","unstructured":"Jablonska, B. et al. Oligodendrocyte regeneration after neonatal hypoxia requires FoxO1-mediated p27Kip1 expression. J. Neurosci. 32, 14775\u201314793 (2012).","journal-title":"J. Neurosci."},{"key":"54003_CR75","doi-asserted-by":"crossref","unstructured":"Scafidi, J. et al. Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature 506, 230\u2013234 (2013).","DOI":"10.1038\/nature12880"},{"key":"54003_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nn.3604","volume":"17","author":"N Salmaso","year":"2014","unstructured":"Salmaso, N., Jablonska, B., Scafidi, J., Vaccarino, F. M. & Gallo, V. Neurobiology of premature brain injury. Nat. Neurosci. 17, 341\u2013346 (2014).","journal-title":"Nat. Neurosci."},{"key":"54003_CR77","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ijdevneu.2009.05.009","volume":"27","author":"J Scafidi","year":"2009","unstructured":"Scafidi, J., Fagel, D. M., Ment, L. R. & Vaccarino, F. M. Modeling premature brain injury and recovery. Int. J. Dev. Neurosci. 27, 863\u2013871 (2009).","journal-title":"Int. J. Dev. Neurosci."},{"key":"54003_CR78","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60467","volume":"10","author":"X Zhou","year":"2021","unstructured":"Zhou, X. et al. Qki regulates myelinogenesis through Srebp2-dependent cholesterol biosynthesis. ELife 10, e60467 (2021).","journal-title":"ELife"},{"key":"54003_CR79","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1093\/hmg\/ddu408","volume":"23","author":"S Sahdeo","year":"2014","unstructured":"Sahdeo, S. et al. Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich\u2019s ataxia. Hum. Mol. Genet. 23, 6848\u20136862 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"54003_CR80","doi-asserted-by":"publisher","first-page":"33832","DOI":"10.18632\/oncotarget.26112","volume":"9","author":"S Okazaki","year":"2018","unstructured":"Okazaki, S. et al. Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells. Oncotarget 9, 33832\u201333843 (2018).","journal-title":"Oncotarget"},{"key":"54003_CR81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/mp.2016.168","volume":"23","author":"RE Frye","year":"2018","unstructured":"Frye, R. E. et al. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol. Psychiatry 23, 247\u2013256 (2018).","journal-title":"Mol. Psychiatry"},{"key":"54003_CR82","doi-asserted-by":"publisher","unstructured":"Rossignol, D. A. & Frye, R. E. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin (Folinic Acid) treatment in autism spectrum disorders: A Systematic Review and Meta-Analysis j. Pers. Med. 11, https:\/\/doi.org\/10.3390\/jpm11111141 (2021).","DOI":"10.3390\/jpm11111141"},{"key":"54003_CR83","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1046\/j.1460-9568.1999.00873.x","volume":"11","author":"B Nait-Oumesmar","year":"1999","unstructured":"Nait-Oumesmar, B. et al. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur. J. Neurosci. 11, 4357\u20134366 (1999).","journal-title":"Eur. J. Neurosci."},{"key":"54003_CR84","doi-asserted-by":"publisher","first-page":"9752","DOI":"10.1523\/JNEUROSCI.0805-13.2013","volume":"33","author":"H Nakatani","year":"2013","unstructured":"Nakatani, H. et al. Ascl1\/Mash1 promotes brain oligodendrogenesis during myelination and remyelination. J. Neurosci. 33, 9752\u20139768 (2013).","journal-title":"J. Neurosci."},{"key":"54003_CR85","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7816","volume":"9","author":"MK Fard","year":"2017","unstructured":"Fard, M. K. et al. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. Sci. Transl. Med. 9, eaam7816 (2017).","journal-title":"Sci. Transl. Med."},{"key":"54003_CR86","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd, A. F. & Miron, V. E. The pro-remyelination properties of microglia in the central nervous system. Nat. Rev. Neurol. 15, 447\u2013458 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"54003_CR87","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/13543784.2020.1762567","volume":"29","author":"S Gingele","year":"2020","unstructured":"Gingele, S. & Stangel, M. Emerging myelin repair agents in preclinical and early clinical development for the treatment of multiple sclerosis. Expert Opin. Invest. Drugs 29, 583\u2013594 (2020).","journal-title":"Expert Opin. Invest. Drugs"},{"key":"54003_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01732-1","volume":"7","author":"Q Weng","year":"2017","unstructured":"Weng, Q. et al. Folate metabolism regulates oligodendrocyte survival and differentiation by modulating AMPK\u03b1 activity. Sci. Rep. 7, 1705 (2017).","journal-title":"Sci. Rep."},{"key":"54003_CR89","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","volume":"25","author":"B Neumann","year":"2019","unstructured":"Neumann, B. et al. Metformin restores CNS remyelination capacity by rejuvenating aged stem cells. Cell Stem Cell 25, 473\u2013485 (2019).","journal-title":"Cell Stem Cell"},{"key":"54003_CR90","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1177\/1352458519884006","volume":"25","author":"B Neumann","year":"2019","unstructured":"Neumann, B., Segel, M., Chalut, K. J. & Franklin, R. J. M. Remyelination and ageing: Reversing the ravages of time. Mult. Scler. J. 25, 1835\u20131841 (2019).","journal-title":"Mult. Scler. J."},{"key":"54003_CR91","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s12035-014-9019-8","volume":"53","author":"S Apolloni","year":"2016","unstructured":"Apolloni, S., Fabbrizio, P., Parisi, C., Amadio, S. & Volont\u00e9, C. Clemastine confers neuroprotection and induces an anti-inflammatory phenotype in SOD1G93A mouse model of amyotrophic lateral sclerosis. Mol. Neurobiol. 53, 518\u2013531 (2016).","journal-title":"Mol. Neurobiol."},{"key":"54003_CR92","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fncel.2018.00412","volume":"12","author":"W-J Su","year":"2018","unstructured":"Su, W.-J., Zhang, T., Jiang, C.-L. & Wang, W. Clemastine alleviates depressive-like behavior through reversing the imbalance of microglia-related pro-inflammatory state in mouse hippocampus. Front. Cell. Neurosci. 12, 412 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"54003_CR93","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1093\/brain\/awz319","volume":"142","author":"J Van Steenwinckel","year":"2019","unstructured":"Van Steenwinckel, J. et al. Decreased microglial Wnt\/\u03b2-catenin signalling drives microglial pro-inflammatory activation in the developing brain. Brain 142, 3806\u20133833 (2019).","journal-title":"Brain"},{"key":"54003_CR94","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/379257a0","volume":"379","author":"AN Akopian","year":"1996","unstructured":"Akopian, A. N., Sivilotti, L. & Wood, J. N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379, 257\u2013262 (1996).","journal-title":"Nature"},{"key":"54003_CR95","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw8702","volume":"6","author":"BH Varkuti","year":"2020","unstructured":"Varkuti, B. H. et al. Neuron-based high-content assay and screen for CNS active mitotherapeutics. Sci. Adv. 6, eaaw8702 (2020).","journal-title":"Sci. Adv."},{"key":"54003_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.814445","volume":"16","author":"A Rufini","year":"2022","unstructured":"Rufini, A., Malisan, F., Cond\u00f2, I. & Testi, R. Drug repositioning in friedreich ataxia. Front. Neurosci. 16, 814445 (2022).","journal-title":"Front. Neurosci."},{"key":"54003_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36846-w","volume":"14","author":"A Zahaf","year":"2023","unstructured":"Zahaf, A. et al. Androgens show sex-dependent differences in myelination in immune and non-immune murine models of CNS demyelination. Nat. Commun. 14, 1592 (2023).","journal-title":"Nat. Commun."},{"key":"54003_CR98","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1084\/jem.20181965","volume":"216","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y. & Cantley, L. C. Toward a better understanding of folate metabolism in health and disease. J. Exp. Med. 216, 253\u2013266 (2018).","journal-title":"J. Exp. Med."},{"key":"54003_CR99","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3109\/00498254.2013.845705","volume":"44","author":"F Scaglione","year":"2014","unstructured":"Scaglione, F. & Panzavolta, G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica 44, 480\u2013488 (2014).","journal-title":"Xenobiotica"},{"key":"54003_CR100","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/biom12020197","volume":"12","author":"Y Menezo","year":"2022","unstructured":"Menezo, Y., Elder, K., Clement, A. & Clement, P. Folic acid, folinic acid, 5 methyl TetraHydroFolate supplementation for mutations that affect epigenesis through the folate and one-carbon cycles. Biomolecules 12, 197 (2022).","journal-title":"Biomolecules"},{"key":"54003_CR101","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/brainsci10110762","volume":"10","author":"S Mafi","year":"2020","unstructured":"Mafi, S. et al. Pharmacoresistant epilepsy in childhood: Think of the crebral folate deficiency, a treatable disease. Brain Sci. 10, 762 (2020).","journal-title":"Brain Sci."},{"key":"54003_CR102","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5240127","volume":"2016","author":"A Cianciulli","year":"2016","unstructured":"Cianciulli, A., Salvatore, R., Porro, C., Trotta, T. & Panaro, M. A. Folic acid is able to polarize the inflammatory response in LPS activated microglia by regulating multiple signaling pathways. Mediators Inflamm. 2016, 5240127 (2016).","journal-title":"Mediators Inflamm."},{"key":"54003_CR103","doi-asserted-by":"publisher","first-page":"102273","DOI":"10.1016\/j.amsu.2021.102273","volume":"65","author":"T Tommy","year":"2021","unstructured":"Tommy, T. et al. Effect of folinic acid on serum homocysteine, TNFalpha, IL-10, and HMGB1 gene expression in head injury model. Ann. Med. Surg. 65, 102273 (2021).","journal-title":"Ann. Med. Surg."},{"key":"54003_CR104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249\u2013264 (2003).","journal-title":"Biostatistics"},{"key":"54003_CR105","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47\u2013e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"54003_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"54003_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 14, 128 (2013).","journal-title":"BMC Bioinforma."},{"key":"54003_CR108","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","volume":"14","author":"H Mi","year":"2019","unstructured":"Mi, H. et al. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat. Protoc. 14, 703\u2013721 (2019).","journal-title":"Nat. Protoc."},{"key":"54003_CR109","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1124\/dmd.106.012294","volume":"35","author":"JC Kalvass","year":"2007","unstructured":"Kalvass, J. C., Maurer, T. S. & Pollack, G. M. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: Comparison of unbound concentration ratios to in vivo P-glycoprotein efflux ratios. Drug Metab. Dispos. 35, 660\u2013666 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"54003_CR110","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1080\/00498250802499459","volume":"38","author":"SG Summerfield","year":"2008","unstructured":"Summerfield, S. G. et al. Toward an improved prediction of human in vivo brain penetration. Xenobiotica 38, 1518\u20131535 (2008).","journal-title":"Xenobiotica"},{"key":"54003_CR111","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/ci034205d","volume":"44","author":"M Adenot","year":"2004","unstructured":"Adenot, M. & Lahana, R. Blood-brain barrier permeation models: Discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates. J. Chem. Inf. Comput. Sci. 44, 239\u2013248 (2004).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"54003_CR112","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/157340906777441663","volume":"2","author":"R Benigni","year":"2006","unstructured":"Benigni, R. & Bossa, C. Structural alerts of mutagens and carcinogens. Curr. Comput. Aided Drug Des. 2, 169\u2013176 (2006).","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"54003_CR113","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1021\/jm040835a","volume":"48","author":"J Kazius","year":"2005","unstructured":"Kazius, J., McGuire, R. & Bursi, R. Derivation and validation of toxicophores for mutagenicity prediction. J. Med. Chem. 48, 312\u2013320 (2005).","journal-title":"J. Med. Chem."},{"key":"54003_CR114","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1021\/ci0503715","volume":"46","author":"J Kazius","year":"2006","unstructured":"Kazius, J., Nijssen, S., Kok, J., B\u00e4ck, T. & Ijzerman, A. P. Substructure mining using elaborate chemical representation. J. Chem. Inf. Model. 46, 597\u2013605 (2006).","journal-title":"J. Chem. Inf. Model."},{"key":"54003_CR115","doi-asserted-by":"publisher","first-page":"8318","DOI":"10.1523\/JNEUROSCI.23-23-08318.2003","volume":"23","author":"L Bouslama-Oueghlani","year":"2003","unstructured":"Bouslama-Oueghlani, L., Wehrl\u00e9, R., Sotelo, C. & Dusart, I. The developmental loss of the ability of Purkinje cells to regenerate their axons occurs in the absence of myelin: an in vitro model to prevent myelination. J. Neurosci. 23, 8318\u20138329 (2003).","journal-title":"J. Neurosci."},{"key":"54003_CR116","doi-asserted-by":"crossref","unstructured":"Fagel, D. M. et al. Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp. Neurol. 1, 77\u201391 (2005).","DOI":"10.1016\/j.expneurol.2005.04.006"}],"updated-by":[{"DOI":"10.1038\/s41467-025-55864-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54003-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T03:03:12Z","timestamp":1736478192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54003-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54003"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54003-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.08.607135","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-025-55864-4","URL":"https:\/\/doi.org\/10.1038\/s41467-025-55864-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jean-Baptiste Hure, Carlos Parras, Olivier Raineateau, and Louis Foucault are inventors in the patent entitled \u2018Organic molecules for 1312 treating myelin pathologies\u2019, published on September 28th, 2023 (WO2023180474) that is based on most of the data published in this study. Patent applicants: ICM - Paris Brain Institute, INSERM, CNRS, AAPHP, Sorbonne Universit\u00e9, Universit\u00e9 Claude Bernard Lyon 1. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9837"}}